Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2009-11-23
Target enrollment:
Participant gender:
Summary
This study will evaluate the overall remission rate of treatment with vosaroxin (formerly
voreloxin) Injection in patients at least 60 years of age with previously untreated AML